Cardiolipin as a Novel Target for Neuroprotection after Spinal Cord Injury
Cardiolipin as a Novel Target for Neuroprotection after Spinal Cord Injury
批准号:
10084223
负责人:
XIAO-MING XU
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-01-01 至 2021-12-31
关键词:
AcuteAdultAffectAfghanistanAmericanAntioxidantsApoptosisApoptoticArachidonic AcidsAttenuatedBehavioralCASP3 geneCardiolipinsCell DeathCell membraneChestClinicalContusionsDataDocosahexaenoic AcidsDoseFreedomFunctional disorderGenerationsGuanosine Triphosphate PhosphohydrolasesIn VitroIncidenceInjuryInner mitochondrial membraneIraqLeadLinoleic AcidsLipidsMass Spectrum AnalysisMechanicsMediatingMedicalMedical HistoryMilitary PersonnelMitochondriaModelingMolecularMorphologyNatureNeuronal InjuryNeuronsOptic AtrophyOxidative StressOxidesPathologicPathologyPathway interactionsPhospholipidsPlayPolyunsaturated Fatty AcidsProcessQuality of lifeRattusReactive Oxygen SpeciesRecoveryRecovery of FunctionRoleSignal PathwaySignal TransductionSpinal CordSpinal Cord ContusionsSpinal InjuriesSpinal cord injurySpinal cord injury patientsStructureSystemTerrorismTherapeuticTimeTissuesTranslatingTraumatic Brain InjuryTreatment EfficacyVeteransWarbaseclinically relevantcombat casualtycytochrome cdimereffective therapyfunctional disabilityimprovedin vivoin vivo Modellipidomicsmembermitochondrial dysfunctionneuron apoptosisneuron lossneuroprotectionnovelnovel therapeutic interventionoperationoxidationperoxidationrepair strategyrepairedrestorationwounded service member
中文摘要
脊髓损伤(SCI)是影响美国军队受伤人员的最严重的致残性疾病之一。
不幸的是,SCI患者还没有有效的治疗方法。因此,这是一个紧迫的
医学需要开发新的修复策略,以减轻SCI的破坏性,并将其转化为
在临床上改善脊髓损伤退伍军人的生活质量。最近,一种新的脂质信号通路,即
已经鉴定了控制细胞死亡/凋亡的心磷脂(CL)-细胞色素c途径。CL是
结构独特的二聚体磷脂位于线粒体内膜,在那里它是必需的,
最佳线粒体功能CL是神经元损伤中的首选氧化底物,是唯一的磷脂
在细胞凋亡过程中经历早期氧化的线粒体中,是活性氧的早期靶点
物种(ROS)攻击。CL的改变与各种线粒体功能障碍有关,
病理条件。在SCI中首次使用基于质谱的脂质组学,我们生成了
初步数据显示SCI后CL过氧化和损失。值得注意的是,XJB-5-131(XJB),一本小说,
脊髓损伤后30分钟给予的靶向抗氧化剂显著减少了组织损伤,
改善成年大鼠的行为恢复。这些数据有力地表明,CL改变是一个关键机制,
介导损伤诱导的细胞死亡和组织损伤。然而,CL改变的作用和机制
在SCI中仍不清楚。在这里,我们假设CL的改变,包括过氧化和损失,是一个中心的,
过程介导脊髓继发性损伤,CL水平的恢复可能导致
脊髓损伤后的神经保护和功能恢复。利用大鼠脊髓神经元体外培养系统,
成年大鼠胸部挫伤性SCI模型,我们将确定1)CL改变是否诱导
线粒体功能障碍和神经元死亡,以及这种有害作用是否可以通过一种新的
线粒体靶向抗氧化剂XJB; 2)CL改变在线粒体靶向抗氧化剂XJB信号通路中的分子作用。
SCI后神经元凋亡以及这种CL改变是否足以介导继发性SCI; 3)是否
异常的线粒体动力学也在CL改变介导的细胞死亡中起作用;和4)最佳剂量
XJB对大鼠脊髓损伤后神经保护和功能恢复的治疗时间窗。
英文摘要
Spinal cord injury (SCI) is among the most disabling conditions affecting wounded members of the U.S. military.
Unfortunately, there has been no effective treatment available for SCI patients. It is, therefore, an urgent
medical need to develop novel repair strategies to mitigate the devastating nature of SCI and to translate them
clinically to improve quality of life of our veterans with SCI. Recently, a novel lipid signaling pathway, namely
the cardiolipin (CL)-cytochrome c pathway, that control cell death/apoptosis has been identified. CL is a
structurally unique dimeric phospholipid localized in the inner mitochondrial membrane where it is required for
optimal mitochondrial function. CL is a preferred oxidation substrate in neuronal injury, is the only phospholipid
in the mitochondria that undergoes early oxidation during apoptosis, and is an early target of reactive oxygen
species (ROS) attack. Alteration of CL has been associated with mitochondrial dysfunction in a variety of
pathological conditions. Using mass spectrometry-based lipidomics for the first time in SCI, we have generated
preliminary data showing CL peroxidation and loss after SCI. Remarkably, XJB-5-131 (XJB), a novel
mitochondria-targeted antioxidant, administered at 30 min post-SCI significantly reduces tissue damage and
improves behavioral recovery in adult rats. These data strongly suggest that CL alteration is a key mechanism
that mediates injury-induced cell death and tissue damage. However, the role and mechanism of CL alteration
in SCI remain unclear. Here, we hypothesize that CL alteration, including peroxidation and loss, is a central
process that mediates spinal cord secondary injury, and that restoration of CL level may lead to
neuroprotection and recovery of function after SCI. Using a rat spinal cord neuronal culture system in vitro and
an adult rat thoracic contusive SCI model in vivo, we will determine 1) whether CL alteration induces
mitochondrial dysfunction and neuronal death and whether such detrimental effects can be reversed by a novel
mitochondrial targeted antioxidant XJB; 2) the molecular role of CL alteration in the signaling pathway of
neuronal apoptosis after SCI and whether such CL alteration is sufficient to mediate secondary SCI; 3) whether
abnormal mitochondrial dynamics also play a role in CL alteration-mediated cell death; and 4) an optimal dose
and therapeutic time window of XJB on neuroprotection and functional recovery after rat contusive SCI.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1038/s41598-020-74128-3
发表时间:
2020-10-28
期刊:
Scientific reports
影响因子:
4.6
作者:
[Peng K, Sant D, Andersen N, Silvera R, Camarena V, Piñero G, Graham R, Khan A, Xu XM, Wang G, Monje PV]
通讯作者:
Monje PV
Reprogramming reactive glial cells into functional new neurons after SCI
-
批准号:10218281
-
项目类别:
-
资助金额:$52.2万
-
财政年份:2020
-
负责人:XIAO-MING XU
-
依托单位:
Reprogramming reactive glial cells into functional new neurons after SCI
-
批准号:10055803
-
项目类别:
-
资助金额:$53.59万
-
财政年份:2020
-
负责人:XIAO-MING XU
-
依托单位:
Exercise and NT-3-mediated lumbar motoneuron plasticity and recovery after SCI
-
批准号:10088336
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:XIAO-MING XU
-
依托单位:
BLR&D Research Career Scientist Award Application for Xiao-Ming Xu, PhD
-
批准号:9911971
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:XIAO-MING XU
-
依托单位:
BLR&D Research Career Scientist Award Application for Xiao-Ming Xu, PhD
-
批准号:10265418
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:XIAO-MING XU
-
依托单位:
BLR&D Research Career Scientist Award Application for Xiao-Ming Xu, PhD
-
批准号:10454214
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:XIAO-MING XU
-
依托单位:
BLR&D Research Career Scientist Award Application for Xiao-Ming Xu, PhD
-
批准号:9764746
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:XIAO-MING XU
-
依托单位:
Role of phospholipase A2 in spinal cord secondary injury
-
批准号:8494696
-
项目类别:
-
资助金额:$31.86万
-
财政年份:2009
-
负责人:XIAO-MING XU
-
依托单位:
Role of phospholipase A2 in spinal cord secondary injury
-
批准号:8305087
-
项目类别:
-
资助金额:$33.01万
-
财政年份:2009
-
负责人:XIAO-MING XU
-
依托单位:
Role of phospholipase A2 in spinal cord secondary injury
-
批准号:7787702
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2009
-
负责人:XIAO-MING XU
-
依托单位:
Role of phospholipase A2 in spinal cord secondary injury
-
批准号:8096555
-
项目类别:
-
资助金额:$33.01万
-
财政年份:2009
-
负责人:XIAO-MING XU
-
依托单位:
Role of phospholipase A2 in spinal cord secondary injury
-
批准号:7925718
-
项目类别:
-
资助金额:$33.35万
-
财政年份:2009
-
负责人:XIAO-MING XU
-
依托单位:
PKC inhibition-mediated spinal cord regeneration
-
批准号:7414381
-
项目类别:
-
资助金额:$30.82万
-
财政年份:2005
-
负责人:XIAO-MING XU
-
依托单位:
PKC inhibition-mediated spinal cord regeneration
-
批准号:7911375
-
项目类别:
-
资助金额:$18.12万
-
财政年份:2005
-
负责人:XIAO-MING XU
-
依托单位:
PKC inhibition-mediated spinal cord regeneration
-
批准号:7485885
-
项目类别:
-
资助金额:$31.19万
-
财政年份:2005
-
负责人:XIAO-MING XU
-
依托单位:
PKC inhibition-mediated spinal cord regeneration
-
批准号:6955587
-
项目类别:
-
资助金额:$33.95万
-
财政年份:2005
-
负责人:XIAO-MING XU
-
依托单位:
PKC inhibition-mediated spinal cord regeneration
-
批准号:7599163
-
项目类别:
-
资助金额:$29.53万
-
财政年份:2005
-
负责人:XIAO-MING XU
-
依托单位:
PKC inhibition-mediated spinal cord regeneration
-
批准号:7069024
-
项目类别:
-
资助金额:$32.28万
-
财政年份:2005
-
负责人:XIAO-MING XU
-
依托单位:
DOMESTIC VIOLENCE--CHINESE WOMEN IN THE US AND IN CHINA
-
批准号:6187489
-
项目类别:
-
资助金额:$2.85万
-
财政年份:2000
-
负责人:XIAO-MING XU
-
依托单位:
DOMESTIC VIOLENCE--CHINESE WOMEN IN THE US AND IN CHINA
-
批准号:2862266
-
项目类别:
-
资助金额:$3.63万
-
财政年份:1999
-
负责人:XIAO-MING XU
-
依托单位:
海外基金